ArticlemedRxiv : the preprint server for health sciences2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir.
Brian P Epling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.